Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Pralidoxime Chloride is used as an antidote in two situations: to treat poisoning caused by pesticides and chemicals (such as nerve agents) of the organophosphate class that have anticholinesterase activity, and to control overdose of anticholinesterase drugs used to treat myasthenia gravis. The main signs that call for its use are muscle weakness and respiratory depression. In severe poisoning, respiratory depression may be the result of muscle weakness.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Pralidoxime Chloride is an acetylcholinesterase reactivator. Its main job is to bring back acetylcholinesterase, mostly outside the central nervous system, after an organophosphate pesticide or a related compound has inactivated it by phosphorylation. Once the enzyme is working again, the build-up of acetylcholine can be broken down, and the neuromuscular junctions can start working normally again.

Pralidoxime Chloride also slows the "aging" of phosphorylated cholinesterase into a form that can no longer be reactivated. It can also break down certain organophosphates through a direct chemical reaction.

The drug works most reliably in relieving paralysis of the muscles used for breathing. Atropine must always be given along with it, because atropine blocks the effect of the acetylcholine that has built up at that site.

The drug reaches the minimum therapeutic level in plasma (4 µg/ml) about 16 minutes after a 600 mg injection of Pralidoxime Chloride. It is cleared quickly in the urine, partly as the unchanged drug and partly as a metabolite made by the liver.

Pregnancy & Breastfeeding

Pregnancy Category C. Pralidoxime chloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this medicine passes into breast milk, so it should be used with caution in breastfeeding mothers.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Adults and children over 16 years: Give an initial dose of 1000 to 2000 mg of Pralidox (Pralidoxime Chloride), preferably as an infusion in 100 ml of normal saline over 15 to 30 minutes. If this is not practical, or if pulmonary oedema is present, give the dose slowly by intravenous injection (over not less than 5 minutes) as a 50 mg/ml solution (for example, 1000 mg in 20 ml). A second dose of 1000 to 2000 mg may be needed after about one hour if muscle weakness has not been relieved. Further doses may be given every 10 to 12 hours if muscle weakness persists. Children 16 years and under: Loading dose: 20 to 50 mg/kg (maximum 2000 mg per dose) over 15 to 30 minutes. Maintenance infusion: 10 to 20 mg/kg per hour. Alternatively, a repeat bolus of 20 to 50 mg/kg (maximum 2000 mg per dose) may be given after 1 hour and repeated every 10 to 12 hours thereafter, as needed. Preparation for administration: For intravenous infusion, reconstitute a single Pralidox (Pralidoxime Chloride) 1000 mg vial by adding 20 ml of Normal Saline (0.9% Sodium Chloride solution) for Injection using a 10 ml syringe; this gives a concentration of 50 mg/ml. Dilute the solution further with the remaining Normal Saline to reach a concentration of 10 to 20 mg/ml (for example, 1000 mg in 100 ml or 2000 mg in 100 ml). For fluid-restricted patients, or for rapid administration (over at least 5 minutes), a maximum concentration of 50 mg/ml may be used. Discard any unused solution once the dose has been withdrawn.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →